DRI Healthcare Trust acquires royalty stake in cataract drug Omidria

DRI Healthcare Trust is wholly owned subsidiary of DRI Capital, a Canadian healthcare royalty private equity manager.

3 October 2022•2 mins read
LinkedInXEmail
LinkedInXEmail

Related articles